Heidi Anne Duerr, MPH

The newest class of medications to treat insomnia have many advantages.

Elizabeth Lowenhaupt, MD, CCHP, shares her insights and experiences on correctional psychiatry and juvenile mental health as she looks toward the future of the field.

Following a long path to approval, gepirone hydrochloride extended-release tablets (Exxua) is the first FDA-approved medication with this novel mechanism of action for adults with MDD.

What's new in sleep research?

In the largest study of its kind to date, researchers found promising results for subcutaneous ketamine for treatment resistant depression.

Did you miss our APA Annual Meeting coverage?

Data presents opportunities to enhance care and improve treatment adherence.

Poster presented at the 2023 American Psychiatric Association Annual Meeting highlights the good and bad of social media information.

Session at the 2023 Annual Meeting provides framework for addressing suicidal ideation.

Research explores the differences between new-onset psychosis in patients with infection versus healthy controls.

Study results presented at the 2023 American Psychiatric Association Annual Meeting.

Leveraging evolutionary psychiatry may help clinicians and patients alike.

Test your knowledge on issues in major depressive disorder.

First of its kind culturally sensitive adherence scale factors in CVD risk factors to find ways to best support patients.

Innovation award presented to early career psychiatrist promotes exploration and research in the use of neurostimulation for psychiatric disorders.

Here are 9 things you need to know about the clinical management of major depressive disorder.

“The sooner you can recognize and diagnose bipolar, the sooner you can institute effective evidence-based treatments.”

Many individuals do not get medical support for insomnia. Here's how you can help.

Check out the best clinical pearls from the 2022 Neuroscience Education Institute (NEI) Congress!

New research explores the impact of GAT on TGNC youth.

What are the advances in adult ADHD?

Is there one state-of-the-art treatment for depression?

How did patients with BDI and obesity fare in new research looking at quality of life issues?

A conference poster shared an unusual case of hallucinations.

There are no treatment guidelines for ADHD in adults in the United States, but you can still tackle this challenging diagnosis.

"DTx offer solutions in a number of very challenging spaces and access to care."

Why are more and more adult women being diagnosed with ADHD? A presentation at the APNA Annual Conference shed light on the issue.

Opioid use, addiction, and overdose in youth continue to increase. What can be done?

Opioid use disorder—how can we battle the epidemic of overdoses?